| Dr Laura Johanna Harlan, DO | |
|
5401 Old Court Rd, Randallstown, MD 21133-5103 | |
| (410) 521-5950 | |
| Not Available |
| Full Name | Dr Laura Johanna Harlan |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 5401 Old Court Rd, Randallstown, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972552859 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | HOO51339 (Maryland) | Primary |
| Entity Name | Mep Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164483558 PECOS PAC ID: 5193610319 Enrollment ID: O20050105000930 |
News Archive
When it comes to lipid profiles - a key measure of heart disease risk- it appears that African-Americans and women have it better than whites and men, according to a new study by Duke University Medical Center researchers.
Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks, today announced results for the second quarter ended May 31, 2010. Consolidated revenues for the second quarter of fiscal 2010 were $4.3 million compared to $4.7 million for the second quarter of fiscal 2009.
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead product, NKP-1339. NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein processing and a tumor survival factor.
Nearly 35 percent of all the imaging costs ordered for 2,068 orthopaedic patient encounters in Pennsylvania were ordered for defensive purposes, according to a new study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.
› Verified 9 days ago
| Entity Name | Center For Vein Restoration Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770741753 PECOS PAC ID: 8729022736 Enrollment ID: O20081014000462 |
News Archive
When it comes to lipid profiles - a key measure of heart disease risk- it appears that African-Americans and women have it better than whites and men, according to a new study by Duke University Medical Center researchers.
Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks, today announced results for the second quarter ended May 31, 2010. Consolidated revenues for the second quarter of fiscal 2010 were $4.3 million compared to $4.7 million for the second quarter of fiscal 2009.
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead product, NKP-1339. NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein processing and a tumor survival factor.
Nearly 35 percent of all the imaging costs ordered for 2,068 orthopaedic patient encounters in Pennsylvania were ordered for defensive purposes, according to a new study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.
› Verified 9 days ago
| Entity Name | Mep Observation Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093003550 PECOS PAC ID: 2365611845 Enrollment ID: O20110818000338 |
News Archive
When it comes to lipid profiles - a key measure of heart disease risk- it appears that African-Americans and women have it better than whites and men, according to a new study by Duke University Medical Center researchers.
Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks, today announced results for the second quarter ended May 31, 2010. Consolidated revenues for the second quarter of fiscal 2010 were $4.3 million compared to $4.7 million for the second quarter of fiscal 2009.
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead product, NKP-1339. NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein processing and a tumor survival factor.
Nearly 35 percent of all the imaging costs ordered for 2,068 orthopaedic patient encounters in Pennsylvania were ordered for defensive purposes, according to a new study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Johanna Harlan, DO 11 Wilderfield Ct, Lutherville, MD 21093-4758 Ph: (410) 828-5590 | Dr Laura Johanna Harlan, DO 5401 Old Court Rd, Randallstown, MD 21133-5103 Ph: (410) 521-5950 |
News Archive
When it comes to lipid profiles - a key measure of heart disease risk- it appears that African-Americans and women have it better than whites and men, according to a new study by Duke University Medical Center researchers.
Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks, today announced results for the second quarter ended May 31, 2010. Consolidated revenues for the second quarter of fiscal 2010 were $4.3 million compared to $4.7 million for the second quarter of fiscal 2009.
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead product, NKP-1339. NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein processing and a tumor survival factor.
Nearly 35 percent of all the imaging costs ordered for 2,068 orthopaedic patient encounters in Pennsylvania were ordered for defensive purposes, according to a new study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.
› Verified 9 days ago
Debra Freeman, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-5950 | |
Dr. Jennifer Ann Yorke, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5401 Old Court Rd, Northwest Hospital Emergency Dept, Randallstown, MD 21133 Phone: 410-521-5950 | |
Aminat Ibikunle, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-2200 | |
Dr. Jonathan Sidney Thierman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-5950 | |
Dr. Michael De Wit, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 410-521-5950 | |
Ryleigh Marie Etzweiler, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5401 Old Court Rd, Randallstown, MD 21133 Phone: 000-000-0000 | |
Thomas J Krisanda, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5401 Old Court Road, Northwest Hospital Emergency Dept., Randallstown, MD 21133 Phone: 410-521-5950 Fax: 410-828-6004 |